MEDICINAL BIOMAGNETISM FOR THE TREATMENT OF OBESITY
OBESITY (Português (Brasil))

Keywords

Medicinal Biomagnetism; Magnetic Therapy; Protocol; Static Magnetic Fields; Inflammation; Obesity; Edema; Detox.

How to Cite

Vergínia Campagnollo Bueno, A. ., Gonçalves Seneda, M. ., Mara Rambo, Ângela ., Clara Campagnolo Gonçalves Toledo, A. ., Cabral de Azevedo, C. ., & Viapiana Bossa, A. . (2023). MEDICINAL BIOMAGNETISM FOR THE TREATMENT OF OBESITY : PRESENTATION OF THE 3D PROTOCOL. Health and Society, 3(01), 411–437. https://doi.org/10.51249/hs.v3i01.1181

Abstract

Obesity is a chronic disease that affects a large part of the population and can develop several outcomes such as cardiovascular disease, type II diabetes and some types of cancer. As a result, it favors negative aspects both for the individual and for the public power. Faced with this problem, there is a need for new forms of treatment to improve the quality of life of these patients and reduce public spending. New alternatives to traditional medicine are needed for complementary non-drug treatments. Among them is Medicinal Biomagnetism (MB), a technique developed by Dr. Isaac Goiz Durán, which aims to promote body homeostasis using medium intensity magnets. It is believed that this tool can act positively in the control management, and improvement of fluid retention in the body in obese individuals. Objective: This study aims to present and compile the MB 3D Protocol for the treatment of obesity with the published evidence on Static Magnetic Fields (SMFs) applied in obesity. Materials and Methods: Qualitative and exploratory descriptive literature review. Results: Some studies were found that demonstrated that MB therapy can be beneficial for the treatment of obesity. The 3D Protocol has therapeutic potential to produce positive effects, being able to balance the body’s homeostasis by helping to regulate metabolism. Conclusion: Treatments with SMFs have beneficial effects on several aspects of obesity, which supports future studies that evaluate the results of applying the 3D Protocol in this area.

 

https://doi.org/10.51249/hs.v3i01.1181
OBESITY (Português (Brasil))

References

Claro RM, Monteiro CA, França GVA, Oliveira PPV, Gouvêa ECDP, Silva LES et al. Brasília DF Secretaria de Vigilância e Saúde. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília. 2021.

Alves PHR, Corrêa CR. Relação entre Resposta Imune Inata do Receptor Toll-Like-4 (TLR-4) e o Processo Fisiopatológico da Cardiomiopatia da Obesidade. Arquivos Brasileiros de Cardiologia. Botucatu. 2021; 117 (1): 91-99. doi: 10.36660/abc.20190788.

The World Health Organization [homepage na internet]. Obesity and overweight [acesso em 23 oct 2022]. Genebra. 2021. Disponível em: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Chew NWS, Kong G, Venisha S, Chin YH, Han NC, Muthiah M et al. Long-Term Prognosis of Acute Myocardial Infarction Associated with Metabolic Health and Obesity Status. Endocrine Practice. [place unknown]. 2022; 30 (5): 802-810. doi: 10.1016/j.eprac.2022.05.007.

Nchidzi N, Letamo G, Keetile M. Prevalence of and factors associated with hypertension, diabetes, stroke and heart attack multimorbidity in Botswana: Evidence from STEPS 2014 survey. [place unknown]. 2022; 24 (3): 1-16.

Veum VL, Borge JL, Eng Ø, Rostrup E, Larsen TH, Nordrehaug JR et al. Visceral adiposity and metabolic syndrome after very high–fat and low-fat isocaloric diets: A randomized controlled trial. The American journal of clinical nutrition. [place unknown]. 2017;105(1):85-99.

Ezequiel DG, Costa MB, Pinheiro HS. Obesidade: da fisiopatologia ao tratamento. HU rev. Juiz de fora. 2019; 44(2): 147.

Karra P, Winn M, Pauleck S, Jacobsen AB, Peterson Lacie, Coletta A et al. Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. [place unknown]. 2022;30(7): 1323-1334. doi: 10;1002/oby.23444.

Freitas C, Damasceno JL, Santos RA, Pina MGM. Obesidade e sua influência sobre o câncer: uma recente revisão da literatura. Revista de Atenção à Saúde. São Caetano do Sul. 2021;19(67): 344-356. doi: 10.13037/ras. vol19n67.7362.

Park SK, Jung JY, Oh CM, Choi JM, Kim MH, Ha E. Components of metabolic syndrome and their relation to the risk of incident cerebral infarction. Endocrine Journal. Japão. 2021; 68(3): 253-259.

Skilnik WL. Aprendizado de estruturas de dependência entre fenótipos da síndrome metabólica em estudos genômicos [dissertação]. São Paulo: Universidade de São Paulo, Faculdade de Saúde Pública; 2017 [citado 2022-10-20]. doi:10.11606/D.6.2017.tde-04072017-105320.

Raposo HF, Basso LS, Delbue JL. Restrição alimentar de carboidratos no tratamento da obesidade. Rev. Ciênc. Méd. Campinas. 2012; 15(1): 56-67.

Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care. [place unknown]. 1997; 20(11): 1744 - 1997.doi: 10.2337/diacare.20.11.1744.

Cao W, Zhang T, Feng R, Xia T, Huang H, Liu C, Sun C. Hoxa5 alleviates obesity-induced chronic inflammation by reducing ER stress and promoting M2 macrophage polarization in mouse adipose tissue. J Cell Mol Med. China. 2019; 23(10):7029-7042. doi: 10.1111/jcmm.14600.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult Treatment Panel III), Final Report. Estados Unidos. The Program. 2002: 1 -293.

Fanghänel G, Cortinas L, Reyes S, Beber A. A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity. International journal of obesity. [place unknown]. 2000; 24 (2):144-150. doi:10; 1038/sj.ijo.0801098.

LI Jinghua. Effects of balanced diet associated with sports on the health of obese university students. Revista Brasileira de Medicina do Esporte. [place unknown]. 2022; 22(1): 1-4. doi: 10.1590/1517-8692202329012022_0183.

Kristoffersen AE, Broderstad AR, Musial F. Prevalence, and health-and sociodemographic associations for visits to traditional and complementary medical providers in the seventh survey of the Tromsø study. BMC complementary and alternative medicine. [place unknown]. 2019; 19 (1): 1-11.

Durán IG. El Par Biomagnético. Chapingo, México D.F. Universidad Autonoma Chapingo. México. 2008; (5): 2-177.

Broeringmeyer R. Principios de La Terapia Magnética. Bio- magnestismo. Health Industries, Inc. [place unknown]. 1991: 3-25.

Martinez DG. Manual del Biomagnetista. Ciudad de México: Biomagnetism Research Institute. Cidade do México. 2019.

Bossa AV. Biomagnetismo Medicinal Avançado, Bioenergética e Desbloqueio Emocional Magnético Avançados. Cascavel - Paraná. Fevereiro-2020; (1): 3-281.

Martínez DG. Protocolos de Biomagnetismo Minibook. Biomagnetism Researh Institute. Cidade do México. 2019: 1–131.

Gil AC. Como elaborar projetos de pesquisa. São Paulo: Atlas 1991.

Miraglia F, Mello ED. Como avaliar o processo inflamatório em crianças com excesso de peso?. Clin Biomed Res. Rio Grande do Sul. 2012; 32 (3): 332-339.

Kim EH, Kim HK, Lee MJ, Bae SJ, Choe J, Jung CH, et al. Sex differences of visceral fat area and visceral-to- subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus. Korean Diabetes Journal. Coréia. 2022; 46(3):486-498.

Li Shuying, Li Shaoping, Ding J, Zhou W. Visceral fat area and body fat percentage measured by bioelectrical impedance analysis correlate with glycometabolism. BMC Endocrine Disorders. China. 2022; 22 (1): 1-8.

Freitas ED, Fernandes AC, Mendes LL, Pimenta AM, Meléndez GV. Síndrome metabólica: uma revisão dos critérios de diagnóstico. Rev. Min. Enferm. [place unknown].2008; 12(3): 403-411.

Garias RD, Teixeira KM, Lagunes A. Programação bioenergética aplicada. [place unknown]. 2022; (4) 3-130.

Van de Velde F, Ouwens DM, Batens AH, Van Nieuwenhove Y, Lapauw B. Divergent dynamics in systemic and tissue-specific metabolic and inflammatory responses during weight loss in subjects with obesity. Cytokine. [place unknown]. 2021 v.144:155587. doi: 10.1016/j.cyto.2021.155587.

Alves PHR, Ferron AJTF, Costa MRC, Hasimoto FK, Gregolin CS, Garcia JL et al. Relação entre Resposta Imune Inata do Receptor Toll-Like-4 (TLR-4) e o Processo Fisiopatológico da Cardiomiopatia da Obesidade. Arq. Bras. Cardiol. [place unknown]. 2021; 117 (1): 91-99. Doi:10.36660/abc.20190788.

Effting PS, Brescianini SMS, Sorato HR, Fernandes BB, Fidelis GSP, Silva PRL et al. Exercício Resistido Modula Parâmetros de Estresse Oxidativo e Conteúdo de TNF-α no Coração de Camundongos com Obesidade Induzida por Dieta. Arquivos Brasileiros de Cardiologia. [place unknown]. 2012; 112(5): 545-552. Doi: 10.5935/abc.20190072 .

Kelly DM, Akhtar S, Sellers DJ, Muraleedharan V, Channer KS, Jones TH. Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse. Endocrine. [place unknown]. 2016; 54(2):504-515.

Souza EFG, Reis BGS, Brito ANM. O papel do adipócito na inflamação e metabolismo do obeso. Research, Society and Development. [place unknown]. 2021; 10 (9):1-10. Doi: 10.33448/rsd-v10i9.18191.

Pereira J, Cesca D, Daronco LSE, Balsan LAG. Efeito do tratamento quiroprático na concentração sérica de proteína C-Reativa e nos sintomas de indivíduos com cervicalgia. Salusvita, Bauru. 2016; 35 (2): 243-257.

Brasil AR, Norton RC, Rossetti MB, Leão E, Mendes RP. C-Reactive protein as an indicator of low intensity inflammation in children and adolescents with or without obesity. Jornal de pediatria. [place unknown]. 2007; 83(5): 477-480. Doi: 10.2223/JPED.1690.

Araújo DB de, Carneiro AAO, Moraes ER, Baffa O. Biomagnestismo: a nova interface entre a física e a biologia. Ciência Hoje. Rio de Janeiro. 1999; 26(153): 24-33.

Perez IPD. O Efeito da Exposição de Campos Magnéticos Estáticos sobre Fibroblastos em Cultura. UFRJ, Rio de janeiro. 2022. Programa de Pós-Graduação Multidisciplinar em Física Aplicada.

Bossa AV. Protocolo de Rastreio do Biomagnetismo Medicinal. Instituto Par Magnético. Cascavel - Paraná. Outubro - 2022; 1(5) 3-122.

Pirrone IYO. Caso clínico de diabetes mellitus tratado con biomagnetismo médico. Segunda parte. [place unknown].

Damyanov C, Maslev I, Pavlov V, Todorov A. A New Treatment Method of Advanced Metastatic Tumors. Ann Clin Case Rep. 2019; (4): 1647.

Damyanov C, Maslev I, Pavlov V, Todorov A. Integrative Oncology at the Clinicist’s Look Chronology for the Creation and Development of the IPT & BMP Method for Treatment of Oncological Diseases. Clin Oncol. Bulgaria. 2019; (4): 1671.

Parra IA. Centro de Enseñanza de la Medicina Tradicional China. Estudio comparado de la aplicación de diferentes técnicas – acupuntura y biomagnetismo – en el tratamiento efectivo de la obesidad. Caracas. 2020; 2-109.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Ana Vergínia Campagnollo Bueno, Michelli Gonçalves Seneda, Ângela Mara Rambo, Ana Clara Campagnolo Gonçalves Toledo, Caroline Cabral de Azevedo, Adriane Viapiana Bossa

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...